chevron_leftBack
As of 21 June 2026, Lactose (India) Ltd. has a market cap of $15.23M USD, ranking #38903 globally and #2887 in India.
It ranks #3478 in the Healthcare sector, and #1141 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$15.23MUSD
1.44B INR
Enterprise Value
$20.52MUSD
1.94B INR
Revenue (TTM)
$15.39MUSD
1.45B INR
EBITDA (TTM)
$1.67MUSD
157.9M INR
Net Income (TTM)
$511.54KUSD
48.28M INR
EBITDA Margin
11%
Profit Margin
3.3%
PE Ratio
29.7
PS Ratio
1.0
PB Ratio
2.3
EV/EBITDA
11.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Atul Maheshwari
open_in_new
Employees
140
Founded
1991
Website
lactoseindialimited.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.9% | -2.9% | 46% | 17% | -1.2% | -4% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
524202
(LACTOSE)
Lactose (India) Ltd
ISIN: INE058I01013
Shares Out.:
Shares Outstanding:
12.589M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
113.07 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Lactose (India) Ltd.
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic. In addition, the company exports its products. Lactose (India) Limited was incorporated in 1991 and is headquartered in Mumbai, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
297K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
121K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
100K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
77K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
65K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
64K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
5M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
4M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
2M%
|
97.4
|
|
SIX: RO
|
$318.3B
2M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
2M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
2M%
|
15.1
|
chevron_leftBack